Canopy Growth (TSX:WEED): Net Loss Skyrockets as Expenses Surge for This Emerging Cannabis Company

Canopy Gowth Corp (TSX:WEED)(NYSE:CGC) exceeds revenue expectations, but surging expenses leave this cannabis company bleeding.

| More on:

Growth stocks in emerging industries that are changing the world definitely have a place in a well-diversified portfolio. But to protect your portfolio from major losses from these risky stocks, keeping them at a relatively small percentage of your portfolio is recommended. Going further than that, holding a basket of these stocks gives you a greater probability that at least one of your higher-risk growth stock holdings will be a winner over the long term.

If we take the auto industry as an example, we can see that while it was clear that the internal combustion engine automobile gave birth to a lucrative industry, which of the early auto companies would survive was less clear. In 1908, there were over 250 automobile manufacturers, while in 1929, there were only 44. And the top three accounted for 80% of the industry’s output.

The lesson here, in my mind, is that with new, emerging industries, we need to exercise caution. The cannabis industry today is rapidly emerging and promises to be a very lucrative one with many winners but also many losers. With so many companies vying for the top spots, it seems clear that not all of them will make it.

In this article, I would like to discuss Canopy Growth’s (TSX:WEED)(NYSE:CGC) fourth-quarter fiscal 2019 earnings that was released yesterday. As one of the leaders, if not the leader, at this time in the cannabis industry, Canopy’s earnings will be very closely watched as a barometre of the state of this emerging industry and its constituents.

Canopy Growth reported a fourth-quarter loss from operations of $174.4 million compared to a third-quarter loss from operations of $157.2 million and a loss of $51 million in the same quarter last year. That’s an 11% bigger loss than last quarter and a 240% bigger loss than last year!

At least net revenue of just over $94 million came in slightly above expectations, rising 312% from the same quarter last year, but this was an only 13.2% sequentially. And the company’s gross margin was significantly lower than last year, coming in at 15.8% versus last year’s gross margin of 33.6%.

These types of results are exactly what has kept me ultra-cautious on Canopy Growth stock. While year-over-year revenue growth is impressive, sequential revenue growth has come down significantly, and the company’s net loss per share came in at a pretty brutal ($0.98).  Canopy Growth stock is trading at a price that is factoring in extremely lofty expectations, and with the stock’s valuations being so high (250 times the consensus 2021 earnings estimate and 123 times trailing sales), the stock will certainly not handle this well.

With 950,000 square feet of production and logistics space, international licences covering over 35 million square feet of production in place, and $4.5 billion in cash and cash equivalents available to the company, Canopy Growth is ramping up nicely in these early stages. That is worth a lot.

But let’s keep in mind, in an emerging industry, it’s a long journey — a long and winding road. And as we have seen in yesterday’s results, there will be growing pains along the way.

I recommend staying tuned in and keeping a close watch for opportunities to add Canopy Growth stock on weakness.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »